Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

NCT00122551 ·Status: TERMINATED ·Phase: PHASE3

Effect on HIV Medications on EPC Cells

NCT03782142 ·Status: COMPLETED

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

NCT05973825 ·Status: NOT_YET_RECRUITING ·Phase: NA

CSP #512 - Options in Management With Anti-Retrovirals

NCT00050089 ·Status: COMPLETED ·Phase: NA

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

NCT00705926 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

NCT03631732 ·Status: COMPLETED ·Phase: PHASE3

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

NCT00775606 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

NCT00504452 ·Status: TERMINATED ·Phase: PHASE2

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

NCT00075907 ·Status: COMPLETED ·Phase: PHASE3

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

NCT00326963 ·Status: COMPLETED ·Phase: PHASE4

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

NCT02097381 ·Status: UNKNOWN ·Phase: NA

Analytical Treatment Interruption in HIV Positive Patients

NCT02590354 ·Status: COMPLETED ·Phase: NA

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

NCT00011128 ·Status: WITHDRAWN ·Phase: PHASE3

Anti-HIV Medications for People Recently Infected With HIV

NCT00106171 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

NCT00454337 ·Status: COMPLETED ·Phase: PHASE3

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

NCT00608569 ·Status: COMPLETED ·Phase: NA

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

NCT00820118 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

NCT02269917 ·Status: COMPLETED ·Phase: PHASE3

Pausing Antiretroviral Treatment Under Structured Evaluation

NCT06031272 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

NCT00562510 ·Status: TERMINATED ·Phase: PHASE3

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

NCT01173510 ·Status: WITHDRAWN ·Phase: PHASE4

An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent

NCT00002091 ·Status: COMPLETED ·Phase: NA

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

NCT01515813 ·Status: WITHDRAWN ·Phase: PHASE2

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

NCT00196638 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

NCT00979706 ·Status: COMPLETED ·Phase: PHASE4